Small Ne­bras­ka start­up hopes to chal­lenge Pfiz­er, Mer­ck in pneu­mo­coc­cal vac­cine race

3 years ago
Startups
R&D

In­ovio’s decades of shift­ing ex­tends to way­ward win­ter in pipeline, work­force thin­ning 

3 years ago
People
R&D

New York City in­vests $20M in­to biotech 'in­no­va­tion space' at the Brook­lyn Navy Yard

3 years ago
Startups
R&D

Am­gen launch­es the first US Hu­mi­ra biosim­i­lar at two dif­fer­ent list prices

3 years ago
Pharma

Af­ter piv­ot­ing from Alzheimer's to bone con­di­tions, biotech piv­ots again — and halves its head­count

3 years ago
People
Deals

Boehringer In­gel­heim touts pre­ven­tion re­sults in rarest form of pso­ri­a­sis

3 years ago
R&D
Pharma

As­traZeneca, No­vo Nordisk and Sanofi score 340B-re­lat­ed ap­peals court win over HHS

3 years ago
Pharma
Law

Roche’s Genen­tech de­buts next it­er­a­tion of MS cam­paign, high­lights ex­pe­ri­ences in Black com­mu­ni­ty

3 years ago
Pharma
Marketing

IRA's price ne­go­ti­a­tion pro­vi­sion would've saved Medicare $26.5B from 2018 to 2020, JA­MA study says

3 years ago
Pharma

Ap­peals court toss­es J&J's con­tro­ver­sial 'Texas two-step' bank­rupt­cy case

3 years ago
Pharma
Law

Charles Riv­er se­cures $50M ac­qui­si­tion of drug dis­cov­ery tech com­pa­ny

3 years ago
Deals
Manufacturing

Or­a­cle ex­ec­u­tive Troy Tazbaz named new FDA di­rec­tor of dig­i­tal health

3 years ago
People
Pharma

‘The field is at a flash­point’: New Chad Mirkin-found­ed biotech hopes to make more ef­fec­tive can­cer vac­cines

3 years ago
R&D

#JPM23: Reg­u­la­to­ry un­cer­tain­ty? What about M&A? Da­ta rule? Alessan­dro Masel­li and John Car­roll take out their crys­tal ...

3 years ago

Cure­Vac touts old­er adult da­ta for GSK-part­nered Covid-19, flu can­di­dates

3 years ago
R&D

Pfiz­er in­vests in Ri­bon Ther­a­peu­tics; Ar­genx gets PDU­FA date ex­ten­sion

3 years ago
News Briefing

Al­to Neu­ro­science bags $25M for four Phase II drugs

3 years ago
Financing
AI

Pfiz­er-backed de­cen­tral­ized co­op­er­a­tive rais­es $4.1M to fund longevi­ty re­search

3 years ago
Financing

Er­ic Lan­der to re­turn to Broad In­sti­tute, one year af­ter White House ex­it over bul­ly­ing al­le­ga­tions

3 years ago
People

FDA ap­proves Italy-based phar­ma's oral SERD for some breast can­cer pa­tients

3 years ago
FDA+

Up­dat­ed: $100B+ in sav­ings? Why the in­com­ing Hu­mi­ra biosim­i­lars will take time to catch on

3 years ago
Pharma

Am­gen lays off about 300 work­ers, cit­ing 'in­dus­try head­wind­s'

3 years ago
People
Pharma

Late Fri­day ap­proval; Trio of biotechs wind down; Stem cell pi­o­neer finds new fron­tier; Biotech icon to re­tire; and ...

3 years ago
Weekly

Bris­tol My­ers, Charles Riv­er join Se­ries A fund­ing for iVex­Sol

3 years ago
Financing
Pharma
First page Previous page 383384385386387388389 Next page Last page
A service from the Financial Times